• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Med Surg (Lond) . Factors associated with increased mortality in hospitalized COVID-19 patients

tetano

Editor, Senior Moderator
Ann Med Surg (Lond)


. 2020 Dec;60:308-313.
doi: 10.1016/j.amsu.2020.10.071. Epub 2020 Nov 4.
Factors associated with increased mortality in hospitalized COVID-19 patients


Chirag Shah[SUP] 1 [/SUP], Donna J Grando[SUP] 1 [/SUP], Rebecca A Rainess[SUP] 1 [/SUP], Lydia Ayad[SUP] 1 [/SUP], Emad Gobran[SUP] 1 [/SUP], Payam Benson[SUP] 1 [/SUP], Meika T Neblett[SUP] 1 [/SUP], Vinod Nookala[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The rapid spread of the coronavirus disease 2019 (COVID-19) epidemic has significantly impacted global health. So far, the evidence regarding the risk factors that predict the outcomes of COVID-19 patients is limited. In this study, we identified several risk factors that are associated with increased mortality in COVID-19 patients.
Methods: We performed a retrospective review of electronic medical records of the patients admitted with an initial diagnosis of COVID-19. We extracted several patient variables (including demographics, lab results, and pre-existing conditions) and examined for their association with increased mortality.
Results: Of the 487 people included in the study, 340 survived and 147 expired. Significant differences existed in demographics and underlying comorbidities between the two groups. A higher proportion of patients were age 65 and older (87.76% vs 53.24%, p < 0.001), and were predominantly male (63.27% vs 52.94%, p = 0.0351). Multivariate analysis showed five variables to be the predictors for mortality: age ≥65 [OR = 3.87, 95% CI (2.01, 7.46), p < 0.001], initial presentation with dyspnea [OR = 1.71, 95% CI (1.03, 2.82), p = 0.037], history of cardiomyopathy [OR = 3.33, 95% CI (1.07, 10.41), p < 0.038], positive initial chest imaging findings [OR = 2.24, CI (1.26, 3.97), p = 0.006], and acute kidney injury (AKI) [OR = 3.33 CI (2.10, 5.28), P < 0.001].
Conclusion: Identifying COVID-19 patients with these characteristics may help guide the management and improve mortality.

Keywords: Acute kidney injury; COVID-19; Cardiomyopathy; Mortality; Risk factors.
 
Back
Top Bottom